A Study to Investigate the Effect of Severely Diminished Liver Function on the Metabolism, Safety, and Tolerability of a Single Oral Dose of Enzalutamide in Men

Clinical trial NCT02138162 · COMPLETED

Trial details

NCT number: NCT02138162
Sponsor: Astellas Pharma Europe B.V.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Severe Hepatic Impairment Normal Hepatic Function

Start date: 2013-08-01
Primary completion: 2014-03-01
Enrollment: 16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.